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Elisabeth Grov Beisland1 
Abstract 
Objective: The aim of this systematic review was to summarize and assess the literature on quality of life (QoL) 
among cancer patients 80 years and older admitted to hospitals and what QoL instruments have been used.
Methods: We searched systematically in Medline, Embase and Cinahl. Eligibility criteria included studies with any 
design measuring QoL among cancer patients 80 years and older hospitalized for treatment (surgery, chemotherapy 
or radiation therapy). Exclusion criteria: studies not available in English, French, German or Spanish. We screened the 
titles and abstracts according to a predefined set of inclusion criteria. All the included studies were assessed accord-
ing to the Critical Appraisal Skills Programme checklists, and the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Statement checklist was used to ensure rigor in conducting and reporting. This systematic review was 
registered in PROSPERO (CRD42017058290).
Results: We included 17 studies with 2005 participants with various cancer diagnoses and Classification of Malig-
nant Tumors stages (TNM). The included studies used a range of different QoL instruments and had different aims 
and outcomes. Both cancer-specific and generic instruments were used. Only one of the 17 studies used an age-
specific instrument. All the studies included patients 80 years and older in their cohort, but none specifically ana-
lyzed QoL outcomes in this particular subgroup. Based on findings in the age-heterogeneous population (age range 
20–100 years), QoL seems to be correlated with the type of diagnosed carcinoma, length of stay, depression and 
severe symptom burden.
Conclusion: We were unable to find any research directly exploring QoL and its determinants among cancer 
patients 80 years and older since none of the included studies presented specific analysis of data in this particular 
age subgroup. This finding represents a major gap in the knowledge base in this patient group. Based on this finding, 
we strongly recommend future studies that include this increasingly important and challenging patient group to use 
valid age- and diagnosis-specific QoL instruments.
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Introduction
The number of people aged 80  years and older is 
expected to increase in Europe [1], and with advancing 
age the risk of being diagnosed with cancer increases: 
36% of all men and 29% of all women older than 75 years 
are currently diagnosed with cancer [2]. An increase in 
the total number of cancer cases among people 80 years 
and older means that more in-hospital cancer treatment 
will be required. In 2018, 25,444 (11,4%) people aged 
80 years and older were hospitalized because of cancer in 
Norway [2]. The main causes of hospital admission were 
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cancer progression, cancer-related signs and symptoms 
(febrile neutropenia, infection, pain, fever and dyspnea), 
treatment-related complications and end-of-life support 
[3, 4].
Cancer treatment can be both complex and difficult for 
patients aged 80  years and older, because of health and 
comorbidities [5, 6].
The World Health Organization (WHO) defines quality 
of life (QoL) as “an individual’s perception of their posi-
tion in life, in the context of the culture in which they 
live and in relation to their goals, expectations, standards 
and concerns” [7]. Currently, the term QoL is often used 
interchangeably with health-related QoL (HRQoL) and 
is measured by the scores of either a generic or disease-
specific QoL questionnaire [8]. Generic means a general 
questionnaire regardless of the illness or condition of 
the patient, whereas disease-specific instruments focus 
on the issues of particular concern to patients with the 
disease [9, 10]. Generic and disease-specific question-
naires are generally accepted as multidimensional assess-
ments of how disease and treatment affect a patient’s 
sense of overall functioning and well-being [11]. Padilla 
et al. [12] defined HRQoL as “a personal, evaluative state-
ment summarizing the positivity or negativity of attrib-
utes that characterize one’s psychological, physical and 
social functioning, and spiritual well-being at a point in 
time when health, illness, and treatment conditions are 
relevant” (p 301–308). Most QoL instruments developed 
over the past 10  years reflect elements of the approach 
advocated by Padilla et  al. [12]. This systematic review 
uses the term QoL, thus indicating a relatively broad def-
inition of QoL. Since there is no clarity about the term 
QoL and different instruments are used to measure QoL 
for older cancer patients [10], this systematic review is 
therefore indicated to provide clarity in this particular 
area, and identify future research endeavors.
Chronic disease-related symptoms such as fatigue [13], 
vomiting, nausea, anxiety, depression [14] and pain [5, 
15] are common among older cancer patients and further 
challenge care management. The presence of multiple 
symptoms and comorbidity was found to be associated 
with decreased functional status and QoL in cancer 
patients [13, 14, 16, 17].
A recent systematic review of studies conducted with 
hospitalized patients undergoing active treatment for 
cancer or receiving palliative care found that older 
patients had more adverse health-related outcomes, 
including more functional dependence, mental distress, 
and depression, longer hospital stays and higher mortal-
ity than younger patients [4]. The presence of multiple 
symptoms and comorbidity were shown to be associated 
with decreased functional status and quality of life [13, 
14, 16, 17].
Given the multiple symptoms and other challenges 
such as multimorbidity, polymedication [18, 19] and 
reduced tolerance for treatment among people aged 
80 years and older with cancer, it could be argued that the 
experience of being hospitalized combined with treat-
ment will adversely affect these patients’ QoL. Accurate 
diagnosis and appropriate care and treatment of cancer-
related problems can improve patients’ QoL [3]. Never-
theless, existing models of health care do not currently 
meet the needs and expectations of this group of patients 
very well [20].
To the best of our knowledge, a systematic review 
exploring QoL among cancer inpatients 80  years and 
older has not yet been published. We found only one sys-
tematic review of QoL during and after cancer therapy 
among patients 65  years and older, but that study only 
included patients with colon cancer [5], thus limiting 
the generalizability to patients with others types of can-
cer. Individual studies have reported QoL and its deter-
minants by cancer diagnosis in homogeneous groups of 
older patients, but to date no attempt has been made to 
systematically evaluate or compare findings across stud-
ies among cancer inpatients 80  years and older. This 
knowledge is essential for facilitating the best possible 
treatment and care for the elderly cancer patients in hos-
pital. In this systematic review, we explored the following 
research question:
In studies that included cancer inpatients undergoing 
treatment aged 80 years and older, how was quality of life 
measured and reported in this specific subgroup?
Methods
This review is registered on PROSPERO [21] and was 
conducted using the Preferred Reporting Items for Sys-
tematic Reviews and Analysis (PRISMA) checklist [22] to 
ensure rigor in conducting and reporting.
Eligibility criteria
Eligible studies were those published and which exam-
ined QoL among patients aged 80  years and older who 
were undergoing cancer treatment. Cancer treatment 
was defined as surgery, chemotherapy and radiation 
therapy. Studies that covered heterogeneous age groups 
were included if the study included participants 80 years 
and older. Eligible studies used any design. Eligible stud-
ies were those that were available in English, French, 
German or Spanish. We did not include gray literature, 
unpublished studies, ongoing clinical trials, theses or dis-
sertations. Studies with low quality were ineligible for 
inclusion in the systematic review.
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Search strategy
The following electronic bibliographic sources were 
searched: Medline (OvidSP 1946–present), Embase 
(OvidSP 1974–present), and Cinahl (Ebscohost 1981–
present). The search was completed in July 2019. The 
search terms included cancer, hospitalization, elderly 
patients and quality of life (Fig.  1). Our PICO (popula-
tion, intervention, comparison and outcome) param-
eters included cancer patients aged 80  years and older 
as our population. Our outcome was measures of QoL. 
The search was created to capture all studies investigat-
ing quality of life of older cancer inpatients undergoing 
cancer treatment. The search strategy was based on the 
search filter created by Semple et al. [8]. Figure 1 shows 
the complete search history in a PRISMA flow chart.
Study selection
We screened all search results by title and abstract 
using Rayyan software [23]. Two reviewers indepen-
dently determined the eligibility of all articles by read-
ing the titles and abstracts. The reviewers resolved any 
disagreement on inclusion or exclusion through discus-
sion. A third reviewer was available if the disagreement 
could not be resolved. Further, if the title and abstract 
did not contain enough information to assess eligibility, 
we screened the full text of the article. Then, in pairs of 
reviewers (JD & RS and EGB & LE), we screened the full 
text of each eligible article.
Data extraction
We developed a data extraction form that enabled us to 
extract the following data: (1) the author, year and coun-
try of publication; (2)  the aim or objective of the study; 
(3)  the design and setting; (4)  the participants and con-
trol group; (5) the QoL instrument used in the study; and 
(6) the primary results of the study and the authors’ con-
clusions. The reviewers (EGB, JD, LSPE and RMS) inde-
pendently extracted the data and double-checked each 
other’s data. The reviewers resolved any disagreement 
about data extraction by discussion.
Quality appraisal
We assessed the quality of the 17 included articles by 
using the Critical Appraisal Skills Programme (CASP), 
which comprises checklists adapted to the various study 
designs. The reviewers independently evaluated each 
article and resolved disagreements by consensus. Critical 
assessment of the studies was graded according to differ-
ent design-specific CASP checklists, from 25% of crite-
ria met, 50% of criteria met, 75% of criteria met to 100% 
of criteria met CASP checklists [24, 25]. The last column 
of Table 1 reports the result of each study. Studies were 
appraised as having high quality when 100% of the cri-
teria were met. Studies were classified as having a risk 
of low quality when 25% of criteria were met and were 
excluded from the systematic review. The main methodo-
logical drawbacks were reported.
Data synthesis and analysis
The included studies differed in study design, cancer pop-
ulation, QoL instruments and statistical analysis used, 
and the results were therefore synthesized narratively 
(Table 1).
Results
We included 17 studies that had patients aged 80  years 
and older in their cohorts. Since none of the studies pre-
sented estimates of QoL in this particular subgroup of 
patients, no direct evidence was found on QoL among 
cancer inpatients aged 80 years and older. Only one of the 
included studies used an age-specific QoL instrument.
PRISMA Flow Chart
Records aer deduplicang (3332), case reports (55), and 
conference abstracts (34) were removed
(n = 3243)
Some overlap between Case Reports and Conference Abstracts 
Records excluded
(n = 3159)
Full-text arcles excluded, with 
reasons
(Paents over 80 not a 
subgroup, n = 49)
(Not in somac hospitals, n = 4)
(No QoL measures, n = 33)
(Languages that require 
translaon, n = 5)
(Type of material, n = 1)
Studies included in 
synthesis
(n = 17)
Records idenfied through database searching
(Medline 1946 - June 27, 2019, n = 1777)
(Embase 1974 - 2019 July 01, n = 1986)
(Cinahl 1981 – 2019, n = 742)
In total n = 4505
Records screened
(n = 3243)
Full-text arcles assessed 
for eligibility
(n = 84)
Fig. 1 PRISMA flow chart
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Study selection
We pooled the search results from the three databases. 
The review group screened 2953 titles and abstracts 
according to a predefined set of inclusion criteria, 
found 84 eligible studies, screened them in full text and 
excluded 67 of these. The primary reason for exclusion 
at this stage was the fact that patients 80 years and older 
were not included or that QoL was not measured (Fig. 1).
Characteristics of the included studies
This review included 2005 participants from 11 coun-
tries. Most of the studies were conducted in the United 
States (n = 5), followed by China and Japan (n = 2). In 
studies that provided information on participants’ ages, 
the ages ranged from 20 [19] to 100 years [24], and only 
two studies stated how many participants were older than 
80 years. No studies analyzed QoL outcomes in the sub-
group of patients aged 80 years and older. The duration 
of the study periods ranged from 7  days to 31  months. 
The sample sizes ranged from 32 to 455. The studies used 
retrospective (n = 1) and prospective (n = 10) cohorts 
and cross-sectional (n = 6) designs. Twelve of the studies 
included only hospitalized patients [20, 24, 25, 27–35], 
and one study included both hospital- and home-based 
patients [36]. Two studies included inpatients in the pal-
liative care unit in the hospital who were undergoing can-
cer treatment [37, 38], and one study included patients 
from palliative home care services and the palliative unit 
of a hospital [39]. One study [40] was a multicenter study 
from 11 cancer centers and a university hospital (Table).
Instruments used to measure QoL
QoL instruments are categorized as either disease-spe-
cific or generic or overall [41]. Most (n = 11) of the 17 
studies used disease-specific instruments to measure 
QoL in cancer [20, 25, 27–29, 31, 33, 36, 38–40]. The 
disease-specific instruments included European Organi-
zation for Research and Treatment (EORTC) Quality of 
Life Questionnaire Core 30 (EORTC-QLQ-C30) [20, 28, 
29, 33, 36, 39, 40], EORTC Quality of Life Care Palliative 
15 (EORTC QLO-C15 PAL) [27, 38, 40], EORTC Qual-
ity of Life esophagus cancer version (EORTC QLQC30-
OES-18) [28] and EORTC Quality of Life pancreas 
version (EORTC-QLQ-PAN- 26) [20]. In addition to the 
EORTC QoL instruments, some studies used other dis-
ease-specific QoL instruments, including the Functional 
Assessment of Cancer Therapy – Leukemia (FACT-
Leuk) [24, 34] and the Functional Assessment of Cancer 
Therapy – Colorectal Cancer (FACT-C) instruments [20, 
24] and the Functional Assessment of Cancer Therapy 
Fatigue (FACT-Fatigue) [24] and Quality of Life Patient/
Cancer Survivor (QoL-CS) version.
Three of the 17 studies used generic instruments [32, 
34, 37]. The generic QoL instruments were WHOQOL-
BREF [32, 37], PROMIS Global Health [34] and WHO-
QOL-OLD [37], which has been validated for use with 
older people. One study used a generic QoL instrument 
comprising the single item “Overall, how would you pres-
ently rate your own life?” [30].
None of the included studies reported on patients’ spir-
itual QoL domain, regardless of the study sample’s age.
How quality of life was reported in the subpopulation 
of cancer patients older than 80 years
QoL was not estimated among the subgroup of inpa-
tients older than 80  years of age in any of the studies, 
even though this specific subgroup was represented in all 
study samples.
How quality of life was reported in the populations studied 
(age range 20–100 years)
A study of the incidence of pancreatic cancer–related 
depression among inpatients with cancer found that the 
type of carcinoma in the digestive system (pancreatic, 
liver, esophageal, gastric and colorectal) and symptoms of 
depression were negatively correlated with QoL, as meas-
ured by the EORTC-QLQ-PAN-26 questionnaire [20], 
QoL domains (global health status, physical functioning 
and emotional functioning) measured by QLQ-C15-PAL 
predict survival among 162 inpatients with advanced 
cancer [38]. In a study of the effectiveness of pallia-
tive care during the end of life of cancer inpatients with 
prostate and lung cancer, found that QoL, as measured 
by QLQ-C15-PAL, was correlated with the type of diag-
nosed carcinoma [27]. In that study, patients with lung 
cancer had lower QoL than patients with colon cancer.
In a study comparing one palliative care unit in a gen-
eral hospital and 10 palliative home care services, the ter-
minally ill cancer inpatients had a statistically significant 
and clinically relevant decrease in nausea and vomiting 
pain and dyspnea compared with the terminally ill cancer 
patients in home care services [39]. Two studies identi-
fied quality of life as higher among patients with lower 
lengths of hospital stays [26, 28]. Postoperatively, patients 
(with esophageal and gastroesophageal junction cancer) 
with length of hospital stays < 10  days had significantly 
better QoL scores in the functional scales (physical, 
emotional, social and role functioning) and in symptom 
scales (fatigue, nausea, dyspnea, appetite loss and dry 
mouth) at 3 and 12 months compared with patients with 
a length of stay > 10 days [28]. Lower pretreatment QoL 
(as measured by FACT-C) was significantly correlated 
with increased length of stay among inpatients undergo-
ing surgery for colorectal cancer [26].
Page 13 of 16Drageset et al. Health Qual Life Outcomes           (2021) 19:98  
Terminally ill cancer inpatients in a palliative care 
center had statistically significantly more symptom sever-
ity and distress, higher depression score and worse physi-
cal health and QoL than the terminally ill cancer patients 
receiving home-based services [36].
Low QoL and severe symptom burden, especially 
fatigue and appetite loss, were observed among the inpa-
tients with malignant disease in one study [29]. Patients 
with instrumental activities of daily living (IADL) dys-
function at baseline were more likely to have reduced 
QoL on role and social functioning after radiation ther-
apy compared with patients without IADL dysfunction 
[33].
Shinozaki et  al. [40] found no significant relation-
ship between QoL scores and functional status among 
terminally ill inpatients with head and neck cancer, and 
depressed inpatients with lung cancer had significant 
worse physical, mental, social and environmental QoL 
than patients who were not depressed [32]. The age 
groups did not differ statistically significantly in global 
QoL among inpatients with bone metastasis, as meas-
ured by the single-item questionnaire [30].
Further, the symptoms of fatigue, anxiety and sleep 
disturbance were associated with reduced QoL among 
adult inpatients with acute leukemia [34], and QoL was 
reported to be poor among 41% of the 29 inpatients with 
high scores in activities of daily living who had under-
gone total gastrectomy for cancer [31]. QoL was not sig-
nificantly associated with functional status in a study of 
terminally ill inpatients with head and neck cancer [40]. 
All these results are based on analyses of age-heterogene-
ous cancer inpatients 20–100 years of age.
Methodological quality of the included studies
Overall, all 17 included studies had high to medium 
methodological quality according to the CASP assess-
ment and met at least 9 of 12 criteria on the checklists 
(high quality) (Table 1, last column). The main methodo-
logical drawbacks of the included studies were related to 
question 5 on confounding factors. Eight of the 17 stud-
ies did not indicate if they had controlled for confound-
ing factors [25, 27–29, 33, 34, 36, 39], creating difficulty 
in drawing conclusions on the validity of the results. Five 
of the studies [26, 27, 34, 35, 39] had limitations related 
to question 8 on the confidence interval estimate of the 
HRQoL or QoL outcome. Two of the studies did not 
report receiving approval by an ethics committee [37, 38].
Discussion
Although the 17 studies included in this systematic 
review did not report QoL specifically among cancer 
inpatients aged 80  years and older, they all included 
participants in this age group. The studies represent dif-
ferent study designs, age and cancer populations, meas-
urement scales and outcomes. The results of this review 
nevertheless provide some indirect insights that will con-
tribute to improving the understanding of QoL among 
patients aged 80  years and older admitted to hospital. 
The results of this review identified that almost all stud-
ies (n = 10) measured QoL using instruments that do not 
measure all aspects of QoL (mental, physical, social and 
spiritual well-being) as defined by Padilla et al. [12].
The spiritual domain would be especially important to 
measure among cancer inpatients older than 80  years, 
since they are approaching the final stage of their life 
and have a severe disease. Nevertheless, this domain 
was only included in two instruments used: WHOQOL-
OLD [37] and the Quality of Life Index [31]. The articles 
did not present the results of the analysis of the spiritual 
domain. Further, the EORTC QLQ-C15-PAL, which does 
not include the spiritual domain, was used in studies of 
advanced cancer and terminally ill patients [27, 38, 40]. 
Spiritual well-being is relevant for older patients under-
going cancer treatment and receiving palliative care 
[42]. QoL measures should therefore be complemented 
by questionnaires that include spirituality to aid health 
care providers in better facilitating the patients’ individ-
ual needs at the end of life. The finding that QoL among 
cancer patients aged 80  years and older has not been 
investigated with validated diagnosis- and age-specific 
instruments is important because evidence is needed to 
inform the development of appropriate health care ser-
vices for this group of patients.
Hospital patients reported worse physical health, QoL 
and symptom burden than those in home care services 
[36, 39] this is due to more severe cases being hospital-
ized. Symptoms among older patients with cancer are 
often reported measured with highly relevant measure-
ment instruments for cancer patients [3–5, 13]. How-
ever, severe symptoms may reduce patients’ overall QoL 
because of distress [41].
For older patients with cancer, preoperative QoL, as 
measured with EORTC-QLQ C30 [25] and FACT-C [28], 
is beneficial in predicting the length of hospital stay for 
different types of cancer. Holloway et  al. [25] reported 
a significant association between lower FACT-C score 
and increased length of stay, where Nafteux et  al. [28] 
reported that QoL, especially poor physical functioning, 
was an independent prognostic factor for longer hospital 
stay.
Only two of the studies [31, 35] provided informa-
tion on Classification of Malignant Tumors TNM stag-
ing. One would assume that a large tumor size would 
inversely correlate with QoL scores. In a recent study of 
patients with renal tumors, preoperative tumor size did 
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not correlate significantly with self-reported QoL. How-
ever, the exception was that patients with the largest 
tumors (> 7.0  cm) reported significantly worse general 
health and QoL (questions 29 and 30 in the QLQ-C30 
questionnaire) [43]. Studies of head and neck cancer 
patients identified that tumor size does not correlate with 
self-reported QoL [44]. Nevertheless, these results are in 
accordance with the study by Vissers et al. [45] that found 
that, regardless of cancer type, comorbidity explains 
more of the variance in QoL than tumor size.
Comorbidities are important factors that often charac-
terize patients aged 80 years and older [16, 46], which in 
turn may affect their QoL [13]. We expected that comor-
bidities could be a plausible confounding factor for older 
people, but only a few studies highlighted this issue [27, 
38, 39, 47].
Another important finding of this review was that older 
patients reported higher levels of pain and received sig-
nificantly fewer opioids for their cancer-related pain than 
middle-aged patients, but their overall QoL did not dif-
fer significantly [30]. However, global QoL scales provide 
no information on the different dimensions of QoL, and 
older patients with higher levels of pain may therefore 
have differed from middle-aged patients with lower levels 
of pain on specific dimensions of QoL. Since cancer pain 
reduces the QoL of older patients and impairs their phys-
ical functioning, sleep, activities of daily living, life enjoy-
ment and mood [48], the measurement of QoL among 
older cancer patients needs to be investigated along all 
the dimensions of QoL to better understand and meet 
their care needs. In future studies, multidimensional 
scales such as the EORTC-QLQ-ELD [48] should be used 
to obtain information on the dimensions of QoL scales 
among older people.
Strengths and limitations of the review
Our review included studies reported in several lan-
guages, including English, French, German and Span-
ish. All 17 studies used QoL as primary outcome. 
Several methodological issues limit the conclusions of 
this review. All the included studies had different designs, 
aims and outcomes. Our review included studies that 
reported a wide age range (20–100 years) and highlighted 
the fact that none of the studies reported separate statis-
tical analysis for people 80  years and older. This limita-
tion makes it difficult to understand how patients aged 
80  years and older experience their QoL during cancer 
treatment. Older people are expected to rate their QoL 
differently from younger people, and different domains 
of QoL, such as the spiritual domain, are more or less 
important in different age groups.
The prospective studies show great variation in the 
sample sizes, from 32 [36] to 455 included participants 
[28]. The heterogeneity of the questionnaires used to 
assess QoL makes comparing the results difficult. We 
found that no studies examined QoL in patients with spe-
cific cancer diagnoses. Hence, including different cancer 
diagnoses in one review might even increase the external 
validity.
For cost reasons and to ensure the quality warranted 
by a peer-review process, we did not search gray litera-
ture, unpublished studies, ongoing clinical trials, theses 
or dissertations. We did not include studies written in 
Chinese, Japanese or Russian.
Conclusions
This review included 17 studies investigating QoL 
among cancer inpatients 80  years and older. Several 
QoL instruments were used, and only one study used 
an age-specific instrument. None of the studies specifi-
cally analyzed QoL outcomes among patients 80 years 
and older. Therefore, no firm conclusion can be drawn 
regarding the evidence on the QoL of cancer inpatients 
80 years and older. This finding represents a major gap 
in the knowledge base in the cancer literature. Based 
on this finding, we strongly recommend future studies 
in this increasingly important and challenging patient 
group using valid age- and diagnosis-specific instru-
ments and conducting subgroup analysis for patients 
80 years and older.
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